Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|September 22, 2012
Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune responseAnna Moles, Ana M Sanchez, Paul S Banks, et al.
Nature Medicine|November 29, 2011
Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver diseaseMohammad R Ebrahimkhani, Fiona Oakley, Lindsay B Murphy, et al.
Hepatology (Baltimore, Md.)|April 11, 2012
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humansJames Pritchett, Emma Harvey, Varinder Athwal, et al.
Hepatology (Baltimore, Md.)|September 7, 2021
Ductular reaction promotes intrahepatic angiogenesis through Slit2-Roundabout 1 signalingMar Coll, Silvia Ariño, Celia Martínez-Sánchez, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 7, 2026
VPS35 controls hepatocellular proliferation through SRC signalling and promotes diethyl nitrosamine-induced tumor initiationMarkus G Barbosa, Dyonne Y Vos, Cristy R C Verzijl, et al.
Molecular Metabolism|July 17, 2024
Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosisPaloma Ruiz-Blázquez, María Fernández-Fernández, Valeria Pistorio, et al.
European Journal of Heart Failure|May 25, 2026
Genetic Determinants of Severity and Recurrence in Arrhytmia-Induced CardiomyopathyColoma Tiron, Marc Soriano-Amores, Raúl Ramos-Polo, et al.
The Biochemical Journal|September 2, 2011
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21Roberta Possenti, Giampiero Muccioli, Pamela Petrocchi, et al.
Alcoholism, Clinical and Experimental Research|October 29, 2009
Alcohol, signaling, and ECM turnoverDevanshi Seth, Nympha B D'Souza El-Guindy, Minoti Apte, et al.
Pageof 8